Autologous haematopoietic stem cell transplantation with busulfan and etoposide as conditioning regimen for acute myelogenous leukaemia patients

被引：0
|
作者：
Ghavamzadeh, A. [1 ]
Alimogaddam, K. [1 ]
Khatami, F. [1 ]
Gaffari, F. [1 ]
Ashuri, A. [1 ]
Mousavi, A. [1 ]
Iravani, M. [1 ]
Bahar, B. [1 ]
Jahani, M. [1 ]
Khodabande, A. [1 ]
机构：
[1] Hematol Oncol & Bone Marrow Transplantat Res Ctr, Tehran, Iran
来源：
BONE MARROW TRANSPLANTATION | 2008年 / 41卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S133 / S134
页数：2
相关论文
共 50 条
  • [21] Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL)
    Jae-Cheol Jo
    Jin Seok Kim
    Je-Hwan Lee
    Jung-Hee Lee
    Sung-Nam Lim
    Sang Min Lee
    Sung-Soo Yoon
    In-Ho Kim
    Sung Hwa Bae
    Yoo Jin Lee
    Yunsuk Choi
    Won-Sik Lee
    Bone Marrow Transplantation, 2020, 55 : 1466 - 1468
  • [22] Comparison of reduced-intensity conditioning regimen to conventional conditioning regimen in allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia
    Fouillard, L
    Labopin, M
    Rocha, V
    Boiron, JM
    Gorin, N
    Polge, E
    Frassoni, F
    BONE MARROW TRANSPLANTATION, 2004, 33 : S13 - S13
  • [23] TEAM (THIOTEPA, ETOPOSIDE, CYTARABINE, MELPHALAN) AS CONDITIONING REGIMEN FOR LYMPHOMA TREATMENT WITH AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION (AHSCT)
    Carella, A. M.
    Palumbo, G.
    Merla, E.
    Greco, M.
    Fontana, A.
    Specchia, G.
    Pisapia, G.
    Mazza, P.
    Guarini, A.
    Rana, A.
    Ditonno, P.
    Ferrara, F.
    Musto, P.
    Pastore, D.
    Scime, R.
    Pellegrini, F.
    Capalbo, S.
    Cavallaro, A. Maria
    Cascavilla, N.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S177 - S177
  • [24] Autologous Stem Cell Transplantation with Moderate Dose of Idarubicin and Busulphan as Conditioning Regimen in Acute Myelogenous Leukemia
    Mashhadi, M. A.
    Ramzi, M.
    Alimoghaddam, K.
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2008, 10 (03) : 202 - 207
  • [25] BUSULFAN PLUS ETOPOSIDE AS A PREPARATIVE REGIMEN FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIA - AN UPDATE
    LINKER, CA
    DAMON, LE
    RIES, CA
    RUGO, HS
    WOLF, JL
    SEMINARS IN ONCOLOGY, 1993, 20 (04) : 40 - 48
  • [26] High dose busulfan, cyclophosphamide and etoposide as a conditioning regimen for autologous progenitor cell transplantation in patients with multiple myeloma.
    Cogle, CR
    Moreb, JS
    Belanger, GL
    Leather, HL
    Boyette, RM
    Finiewicz, K
    Khan, SA
    Reddy, VS
    Wingard, JR
    BLOOD, 2000, 96 (11) : 368B - 368B
  • [27] Continuous infusion idarubicin and intravenous busulphan as conditioning regimen to autologous stem cell transplantation for patients with acute myeloid leukaemia
    Ferrara, Felicetto
    Mele, Giuseppina
    Palmieri, Salvatore
    Pedata, Mariangela
    Copia, Carolina
    Riccardi, Cira
    Izzo, Tiziana
    Criscuolo, Clelia
    Musto, Pellegrino
    HEMATOLOGICAL ONCOLOGY, 2009, 27 (04) : 198 - 202
  • [28] Continuous infusion idarubicin and intravenous busulphan as conditioning regimen to autologous stem cell transplantation for patients with acute myeloid leukaemia
    Ferrara, F.
    Musto, P.
    Palmieri, S.
    Copia, C.
    Pedata, M.
    Izzo, T.
    Criscuolo, C.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S97 - S98
  • [29] Evaluation of busulfan, cyclophosphamide, and etoposide as a preparation regimen for autologous stem cell transplantation in Hodgkin's lymphoma patients
    Bicim, Soykan
    Erkurt, Mehmet Ali
    Kuku, Irfan
    Kaya, Emin
    Berber, Ilhami
    Kaya, Ahmet
    Hidayet, Emine
    Uysal, Ayse
    Sarici, Ahmet
    Ozen, Ilknur Nizam
    IRAQI JOURNAL OF HEMATOLOGY, 2024, 13 (01) : 1 - 6
  • [30] Busulfan/cyclophospharnicle conditioning followed by autologous stem cell transplantation for acute myeloid leukaemia: retrospective multicentre study
    Sohn, SK
    Kim, DH
    Baek, JH
    Kim, JG
    Lee, KB
    Yang, DH
    Kim, YK
    Lee, JJ
    Kim, HJ
    Shin, HJ
    Chung, JS
    BONE MARROW TRANSPLANTATION, 2005, 35 : S377 - S377
12345